Moscow, Russia. Yesterday, the makers of the Russian Sputnik V COVID-19 vaccine, Russia’s Gamaleya Research Institute of Epidemiology and Microbiology on their official Twitter handle announced that their Sputnik V vaccine would be much cheaper than the vaccines of Pfizer and Moderna.

Earlier in August, Russia became the first country to announce that it had registered the first COVID-19 vaccine which they named “Sputnik V” but, they warned that 1 in every 7 of the people who volunteered for the vaccine trials had developed side effects.

On November 11, Russia announced the success story of its Sputnik V, which got an efficacy tag of 92 percent. Similarly, the American vaccine developers Pfizer and Moderna also announced their efficacy report.

Both the Pfizer and Moderna vaccines are already engaged in a tough battle of effectiveness, handling and price.  Sputnik V has officially entered the battle when the official account claimed it to be affordable than the other two vaccines.

The official account said, “Translating pharma lingo: the announced price of Pfizer of USD 19.50 and Moderna of USD 25-USD 37 per dose actually means their price of USD 39 and USD 50-USD 74 per person. Two doses are required per person for the Pfizer, Sputnik V and Moderna vaccines. The price of Sputnik V will be much lower.”

Click here to know more about Sputnik V vaccine 

Also Read:

Here is why Moderna is better than Pfizer vaccine

Early analysis of Pfizer shows 90% efficacy

Side effects seen in every 1 of 7 Sputnik V volunteers in Russia